ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.68
0.00%
US Tech 100
16,886.00
-0.57%
S&P 500
5,035.69
-1.57%
US Dollar vs CAD
1.37675
-0.07%
Bitcoin
58,001.73
-4.29%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. BioCardia Inc (BCDA)

  7. BioCardia Inc (BCDA) News

BCDA BioCardia Inc

0.40
0.0129 (3.33%)
Pre Market
Last Updated: 07:13:10
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
BioCardia Inc BCDA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0129 3.33% 0.40 07:13:10
Open Price Low Price High Price Close Price Previous Close
0.3871
more quote information »

Recent News

Date Time Source Heading
5/01/202406:00GLOBEBioCardia’s CardiAMP Cell Therapy Chronic Myocardial..
4/25/202408:00GLOBEBioCardia Completes Enrollment of CardiAMP Cell Therapy for..
3/27/202415:00GLOBEBioCardia Reports Fourth Quarter and Full Year 2023 Business..
3/20/202406:00GLOBEBioCardia to Host 2023 Financial Results and Corporate..
3/13/202406:00GLOBEBioCardia and StemCardia Announce Biotherapeutic Delivery..
3/12/202406:00GLOBEBioCardia Announces CMS Approval of Coverage for CardiAMP..
3/04/202407:00EDGAR2Form 8-K - Current report
3/04/202407:00GLOBEBioCardia Reports Positive Interim Results from Phase III..
2/27/202415:53EDGAR2Form SC 13D/A - General statement of acquisition of..
2/15/202406:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202416:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202415:17EDGAR2Form S-3 - Registration statement under Securities Act of..
2/09/202408:58EDGAR2Form 8-K - Current report
2/08/202406:03EDGAR2Form 8-K - Current report
2/08/202406:00GLOBEBioCardia Announces Activation of CardiAMP Heart Failure II..
2/06/202415:28EDGAR2Form SC 13D/A - General statement of acquisition of..
2/02/202413:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/31/202406:00EDGAR2Form 8-K - Current report
1/31/202406:00GLOBEBioCardia Announces Two Scientific Abstracts Have Been..
1/03/202406:00EDGAR2Form 8-K - Current report
1/03/202406:00GLOBEBioCardia Biotherapeutic Delivery and Morph Access..
12/19/202306:00EDGAR2Form 8-K - Current report
12/19/202306:00GLOBEBioCardia Doses First Patient in CardiALLO Phase I/II..
12/18/202306:16GLOBEBioCardia Announces Expected CardiAMP Heart Failure Japan..
12/18/202306:00EDGAR2Form 8-K - Current report
12/06/202305:05EDGAR2Form 8-K - Current report
12/06/202305:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/05/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
12/05/202315:11EDGAR2Form 8-K/A - Current report: [Amend]
12/05/202315:05EDGAR2Form 8-K - Current report
11/29/202306:00EDGAR2Form 8-K - Current report
11/29/202306:00GLOBEBioCardia Shares Update from Japan PMDA Consultation on..
11/17/202316:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/16/202316:15EDGAR2Form 8-K - Current report
11/16/202311:56GLOBEBioCardia Announces $1.3 Million Registered Direct Offering..
11/14/202306:15GLOBEBioCardia Announces FDA Approval of CardiAMP Heart Failure..
11/08/202315:11GLOBEBioCardia Reports Third Quarter 2023 Business Highlights and..
11/08/202315:08EDGAR2Form 8-K - Current report
11/08/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/01/202316:04GLOBEBioCardia to Host Q3 2023 Corporate Update and Financial..
10/20/202308:26EDGAR2Form S-3 - Registration statement under Securities Act of..
10/19/202316:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/19/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/19/202316:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/19/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/19/202316:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/19/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/19/202316:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/18/202315:30EDGAR2Form 8-K - Current report
10/11/202305:04EDGAR2Form 8-K - Current report

Your Recent History

NASDAQ
BCDA
BioCardia
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved